The global Non-Vascular Stents Market was valued at USD 1227.66 million in 2022, and it is projected to reach USD 1904.5 million by 2032, experiencing a steady revenue CAGR of 5% throughout the forecast period. The growth of this market is primarily attributed to several key factors. Firstly, there is an increasing prevalence of gastrointestinal and urological problems worldwide, driven by factors like an aging population. Secondly, the preference for minimally invasive procedures has also contributed significantly to the rise in demand for non-vascular stents.
The incidence of gastrointestinal diseases, including pancreatic, esophageal, and colon cancer, is on the rise globally, which in turn, has spurred the demand for non-vascular stents. Moreover, urological conditions such as kidney stones, ureteral strictures, and bladder cancer are becoming more prevalent, further driving the demand for these stents.
One of the main reasons behind the popularity of non-vascular stents among both patients and medical professionals is their minimally invasive nature. These stents not only offer better patient outcomes but also require less time for rehabilitation. As a result, they are increasingly being considered as a preferred treatment option in various medical scenarios.
Get a sample of the report @ https://www.reportsanddata.com/download-free-sample/6312
Major Companies and Competitive Landscape:
The following are some of the major companies operating in the global non-vascular stents market:
- Boston Scientific Corporation
- Cook Medical LLC
- Merit Medical Systems, Inc.
- Medtronic plc
- ConMed Corporation
- Taewoong Medical Co., Ltd.
- ELLA-CS, s.r.o.
- Olympus Corporation
- C. R. Bard, Inc.
- S&G Biotech Inc.
To know more about the report @ https://www.reportsanddata.com/report-detail/non-vascular-stents-market
Driving Factors of Non-Vascular Stents Market:
- Increasing Prevalence of Gastrointestinal and Urological Disorders: The rising incidence of gastrointestinal diseases such as pancreatic, esophageal, and colon cancer, as well as urological conditions like kidney stones, ureteral strictures, and bladder cancer, is fueling the demand for non-vascular stents. These stents are used in the management and treatment of these conditions, driving their adoption in the market.
- Aging Population: As the global population continues to age, the prevalence of age-related medical conditions and diseases increases. Elderly individuals are more susceptible to gastrointestinal and urological problems, and non-vascular stents are often employed in treating such patients due to their minimally invasive nature.
- Inclination Towards Minimally Invasive Procedures: There is a growing preference among patients and healthcare providers for minimally invasive procedures. Non-vascular stents offer an alternative to traditional surgical interventions, as they involve less trauma, shorter hospital stays, and quicker recovery times, contributing to their market growth.
- Technological Advancements: Advances in medical technology have led to the development of innovative non-vascular stents that offer improved functionality, biocompatibility, and patient comfort. These advancements attract healthcare professionals and patients, leading to increased adoption and market expansion.
Restraints of Non-Vascular Stents Market:
- Complications and Risks: Despite being minimally invasive, non-vascular stent placement can still carry certain risks and complications, such as migration, blockage, perforation, or tissue irritation. Concerns related to such adverse events may limit their adoption, especially in certain patient populations.
- High Cost of Procedures: Non-vascular stent placement procedures can be relatively expensive compared to alternative treatments, and this cost factor may hinder their widespread adoption, particularly in regions with limited healthcare resources or lower affordability.
- Stringent Regulatory Approval Process: The regulatory approval process for medical devices, including non-vascular stents, can be lengthy and stringent. Manufacturers must meet specific safety and efficacy standards before their products can enter the market, which may delay their commercialization.
- Availability of Alternative Treatments: In some cases, there are alternative treatment options available for gastrointestinal and urological conditions that may compete with non-vascular stents. These alternatives, such as traditional surgery or medications, could impact the demand for stents in certain scenarios.
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/6312
About Us:
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370a
E-mail: [email protected]
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @ https://www.reportsanddata.com/upcoming-reports
Browse More Latest Reports @ https://www.reportsanddata.com/report
Browse More Reports:
